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Background and purpose — The optimal hip replacement for 
young patients remains unknown. We compared patient-reported 
outcome measures (PROMs), revision risk, and implant costs over 
a range of hip replacements.
Methods — We included hip replacements for osteoarthritis in 
patients under 60 years of age performed between 2003 and 2010 
using the commonest brand of cemented, cementless, hybrid, or 
resurfacing prosthesis (11,622 women and 13,087 men). The ref-
erence implant comprised a cemented stem with a conventional 
polyethylene cemented cup and a standard-sized head (28- or 
32-mm). Differences in implant survival were assessed using 
competing-risks models, adjusted for known prognostic influ-
ences. Analysis of covariance was used to assess improvement in 
PROMs (Oxford hip score (OHS) and EQ5D index) in 2014 linked 
procedures.
Results — In males, PROMs and implant survival were similar 
across all types of implants. In females, revision was statistically 
significantly higher in hard-bearing and/or small-stem cementless 
implants (hazard ratio (HR) = 4) and resurfacings (small head 
sizes (< 48 mm): HR = 6; large head sizes (≥ 48 mm): HR = 5) 
when compared to the reference cemented implant. In component 
combinations with equivalent survival, women reported signifi-
cantly greater improvements in OHS with hybrid implants (22, 
p = 0.006) and cementless implants (21, p = 0.03) (reference, 18), 
but similar EQ5D index. For men and women, National Health 
Service (NHS) costs were lowest with the reference implant and 
highest with a hard-bearing cementless replacement.
Interpretation — In young women, hybrids offer a balance of 
good early functional improvement and low revision risk. Fully 
cementless and resurfacing components are more costly and do 
not provide any additional benefit for younger patients. 

Implants in young patients must perform to a higher level 
while lasting longer. Literature from the 1980s described 
high rates of early loosening and implant failure following 
cemented hip replacement in younger patients (Chandler et al. 
1981, Dorr et al. 1983, Collis 1984, Ranawat et al. 1984, Sharp 
and Porter 1985). These problems drove the development of 
cementless implants; larger, more anatomical head sizes; and 
hard bearings (Lord et al. 1979, Sedel et al. 1990, Cuckler 
et al. 2004, Delaunay et al. 2008). It was hoped that these 
advances would reduce rates of aseptic revision by address-
ing the main causes of failure (polyethylene (PE) debris and 
polymethylmethacrylate-bone interface loosening) and reduce 
early dislocation rates. Resurfacing devices were also intro-
duced to provide an anatomical solution, providing a lower 
risk of dislocation, a perceived greater function, and “easier” 
revision if required (Spencer 2011). Implant failures remain, 
however, but the mode of failure has changed: high disloca-
tion rates with ceramic-on-ceramic (CoC) bearings and metal 
wear-related failures with large-head metal-on-metal (MoM) 
bearings (Sexton et al. 2009, Haddad et al. 2011, Smith et al. 
2012b). 
Findings from worldwide registry data show that cemented 
implants outperform all others, in terms of implant survival 
(Finnish National Arthoplasty Registry 2006, New Zealand 
National Joint Registry 2008, Norwegian Arthroplasty Reg-
istry 2008, Australian National Joint Registry 2010, Swedish 
Hip Registry 2010, England and Wales National Joint Registry 
2012). Following their analysis of the literature, Sedrakyan et 
al. (2011) found that there were no benefits of using hard bear-
ings instead of PE bearings. 
Of the primary hip replacements performed in 2011 in 
England and Wales with patient data available, 20% (13,871 
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We conducted a cohort study using prospectively collected 
patient-level NJR and PROMs data to compare implant sur-
vival and patient-reported outcomes in different primary hip 
replacements. Material costs were analyzed using National 
Health Service (NHS) procurement data. 
Data
We chose the single most commonly used brand of each type 
of hip replacement performed in England and Wales for the 
analysis, in order to control for brand heterogeneity within 
groups: (1) cemented (taper slip design), Exeter V40 stem/
Contemporary cup (Stryker Orthopaedics, Mahwah, NJ) 
(23% of cemented implants); (2) cementless, Corail stem/
Pinnacle cup (DePuy Ltd., Leeds UK) (31% of cementless); 
(3) hybrid, Exeter V40 stem/Trident cup (Stryker Orthopae-
dics) (33% of hybrids); and (4) resurfacing, Birmingham Hip 
Resurfacing (BHR) (Smith and Nephew, Memphis, TN) (55% 
of resurfacings) (England and Wales National Joint Registry 
2012). These implants have been separately stratified into 2 
groups based on revision risk of component options (Jameson 
et al. 2012a, b, 2013b, c). The “best”-performing component 
sets were: cemented Exeter with the Contemporary flanged 
cup and a 28-mm or 32-mm femoral head (metal or ceramic); 
hybrid Exeter with solid shell Trident cup and either a CoC 
bearing or a highly crosslinked PE liner (with either a metal 
head or a ceramic head); cementless Corail stem (size 11 or 
greater) with a Pinnacle cup and a PE liner (metal or ceramic 
head); and BHR using components with a head size of 48 mm 
or greater. All the remaining options had statistically signifi-
cantly higher revision risk and were separately grouped as 
“others”: cemented Exeter with the Contemporary hooded cup 
and/or a head size less than 28 mm; hybrid Exeter with Trident 
multi-hole shell and/or a conventional PE liner; cementless 
small-stem Corail (less than size 11) and/or a Pinnacle cup 
with any hard-bearing liner; and BHR using head sizes of less 
than 48 mm (Figure).
The NJR has collected patient, implant, and surgeon data 
on all hip replacements performed in the public and private 
health systems in England and Wales since 2003. Submission 
of private health system data was mandatory from 2003, but 
public health providers were not obliged to submit data during 
the period of study. Despite this, compliance (the number of 
procedures recorded by the NJR compared with the number 
recorded by the NHS) rose from 60% in 2003 to 100% in 2010 
(England and Wales National Joint Registry 2012). 
In this study, all primary hip replacements were included 
if performed using the specified implants on patients under 
60 years of age and submitted to the NJR between April 1, 
Flow chart describing inclusion criteria.
of 68,331; 7,249 women and 6,622 men) 
were implanted in patients under 60 years 
of age. The majority of these replace-
ments used cementless fixation (either 
fully cementless (60%, 8,372 of 13,871) 
or hybrid (15%, 2,064)), or used a resur-
facing device (8.4%, 1,159). The evidence 
for this practice therefore remains elusive. 
It may be that some combinations improve 
implant survival or function, but the subtle-
ties of brand differences may be lost when 
implants are analyzed within groups, as in 
joint registry analyses.
Implant survival data and patient func-
tional outcome can now be assessed by 
using linked data from the Patient-Reported 
Outcomes Measures (PROMs) project and 
the National Joint Registry (NJR) in Eng-
land and Wales. Hypothesizing that no 
implants offer superior functional outcome 
and survival, we compared different types 
of replacements to identify optimal combi-
nations for young patients, employing the 
most commonly used standard cemented 
hip replacement as the reference case.
methods
Design
NJR data for 
survival analysis
Primary hip replacement with complete patient data
submitted to the National Joint Registry (NJR) database,
performed between April 2003 and 31st December 2010
n = 384,313
Primary hip replacement with pre- 
and post-operative patient reported 
outcome measures (PROMs)
n = 85,215
No linkage possible
n = 28,417
Exclusions:
Patients aged 60 or more
Invalid PROMs data a
Exclusions:
Patients aged 60 or more
Other brands
Rarely used components (<200)
NJR–PROMs linked records
n = 56,798
NJR–PROMs
linked recordsCemented Exeter V40 stem and Contemporary cup
Best = 28/32 mm head with flanged cup
Other = <28 mm head and/or hooded cup
Hybrid Exeter V40 stem and Trident cup
Best = CoC/XLPE liner with solid shell
Other = cPE liner and/or multi-hole shell
Cementless Corail stem and Pinnacle cup
Best = stem size 11+ with any PE liner
Other = CoC/MoM and/or stem size <11
Birmingham Hip Resurfacing
Best = head sizes ≥48 mm
Other = head sizes <48 mm
Performed for osteoarthritis,
valid implant and patient data
n = 111
n = 52
n = 118
n = 213
n = 159
n = 1,117
n = 187
n = 57
n = 885
n = 667
n = 1,140
n = 2,098
n = 920
n = 8,597
n = 6,679
n = 3,723
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2003 and December 31, 2010. There were a number of other 
exclusion criteria: all procedures with an indication other than 
OA (which represents only 7% of procedures (England and 
Wales National Joint Registry 2012); procedures with missing 
implant or patient data; and rarely used implant options. From 
data described in the original studies, between 4.0% and 14% 
of correctly specified procedures on patients with OA were 
excluded due to rarely used implant components or missing 
component data fields. 
The national PROMs project was introduced in 2008 and 
uses validated measures of hip-specific function (Oxford hip 
score (OHS)) (Dawson et al. 1996) and general health status 
(EuroQol (EQ-5D-3L)) (group E 2009), collected preop-
eratively and around 6 months postoperatively (public health 
system patients only). By linking databases at the patient 
level, PROMs data can be combined with the corresponding 
demographic and operative details held in the NJR. To carry 
out linkage, we used a number of criteria: firstly, to ensure 
correct matching, 2 unique identifiers (NJR and procedure 
numbers) recorded in both datasets were used; secondly, the 
operation date recorded by the patient in the PROMs data 
had to be within ± 30 days of the operation date recorded in 
the NJR record, to ensure the patient was scoring the same 
procedure. Procedures with PROMs data that were missing, 
undated, dated more than 12 months prior to or following 
the operation, or non-identical duplicates were excluded; for 
identical duplicates, the first record was retained for analysis. 
Where the presence of a comorbidity was sought in the ques-
tionnaire but left blank by the patient, it was assumed to be 
absent. The study population is summarized in the Figure. The 
demographic, surgical, and implant-related variables available 
for analysis are listed in Table 1 (Supplementary data). 
For this analysis, the patient-reported outcomes of interest 
were improvements between the preoperative and postop-
erative scores (the “change scores”). Change scores, being 
approximately normally distributed, are analytically prefer-
able to postoperative scores (Browne et al. 2007). The OHS 
(score 0–48) has been shown to be a reliable, valid, and 
responsive outcome measure (Murray et al. 2007). A clini-
cally relevant improvement in OHS is considered to be greater 
than 3 (Murray et al. 2007). The EQ-5D-3L index (where 0 
is death, 1 is perfect health, and < 1 is “worse than death”) is 
a measure of health status that is used widely in clinical and 
economic evaluations. Patients are asked about comorbidities, 
general health, and self-reported disability as part of the pre-
operative PROMs questionnaire. These can be used to adjust 
for differences in health status between patient groups. 
In the PROMs after surgery, patients are also requested to 
indicate their satisfaction with the outcome (excellent, very 
good, good, fair, or poor), and whether they deem surgery 
to have been a success (much better, a little better, about the 
same, a little worse, or much worse). While unadjusted values 
of success and satisfaction have been provided for information 
in this study, we made no attempt to adjust for baseline dif-
ferences in these measures, as previous analyses have shown 
that the variables available in the NJR and PROMs databases 
are insufficient to explain any differences (i.e. the influence 
of unmeasured variables has a greater effect than the effect of 
the measured variables) (Browne et al. 2007, Hamilton et al. 
2013).
24,709 procedures were available for analysis in the NJR 
dataset, comprising the most commonly used brands of 
cemented (1,552, 6.3%), hybrid (3,238, 13%), cementless 
(9,517, 39%), and resurfacing (10,402, 42%) replacements 
(Figure). Due to relatively poor compliance and fewer hip 
replacements performed in the early years of the registry, mean 
follow-up time was 2.7 years (median 2.4) despite the fact that 
the range was 0–8 years. Numbers of patients with 6-year sur-
vival data were: 153 best cemented, 212 other cemented, 212 
best hybrid, 244 other hybrid, 107 best cementless, 381 other 
cementless, 1,573 best resurfacing, and 2,223 other resurfac-
ing. Resurfacing procedures were more likely to have been 
performed in younger, fitter patients (Table 2). The majority of 
smaller (< 48-mm head size) resurfacing procedures (“other”) 
table 2. Patient demographics for the national Joint registry population studied, by implant group
 Cemented Hybrid Cementless Resurfacing 
 Best Others Best Others Best Others Best Others p-value a
Number (%) 885 (4) 667 (3) 1,140 (5) 2,098 (9) 920 (4) 8,597 (35) 6,679 (27) 3,723 (15) 
Age, median (range) 56 (23–60) 57 (26–60) 54 (18–60) 55 (20–60) 57 (27–60) 54 (16–60) 52 (19–60) 52 (19–60) < 0.001
Females, n (%) 548 (62) 412 (62) 642 (56) 1,340 (64) 454 (49) 4,880 (57) 432 (7) 2,914 (78) < 0.001
ASA, n (%) b         
 1 263 (30) 193 (29) 430 (38)    677 (32) 252 (27) 2,815 (33) 3,750 (56) 1,969 (53) < 0.001
 2 543 (61) 421 (63) 664 (58) 1,246 (59) 603 (66) 5,233 (61) 2,748 (41) 1,677 (45) 
 3+   79 (9)   53 (8)   46 (4)    175 (8)   65 (7)    549 (6)    181 (3)      77 (2) 
BMI, mean (SD) 30 (6) 30 (5) 30 (5) 30 (6) 30 (5) 30 (5) 29 (4) 28 (5) < 0.001 
 (range) c (18–59) (16–50) (18–56) (16–54) (17–52) (16–65) (16–51) (16–63) 
a Differences between groups. Statistical notes: 1-way analysis of variance (ANOVA) was used for normally distributed data, Kruskal-Wallis test 
for non-normally distributed data, and chi-squared test for proportions;
b ASA: American Society of Anaesthesiologists; 
c BMI: body mass index, kg/m2 (data based on 9,544 procedures (39%)).
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were performed in women (78%). Across the total hip replace-
ment groups, patient variables were clinically very similar, 
although the “best” hybrid procedures were more likely to be 
performed in younger, fitter patients. The entire NJR popula-
tion demographics profile was qualitatively similar to that of 
the smaller NJR-PROMs linked population (Tables 2 and 3). 
Statistics
Implants were analyzed based on previously stratified revi-
sion risk; thus, we compared 8 groups (the optimal implant 
options were defined as “best”, while the remaining options 
were grouped as “other” for each of the 4 types of replace-
ment) (Figure). Differences in baseline characteristics across 
the groups would be a source of confounding in any compara-
tive analysis. Therefore, to test the hypothesis that there were 
no differences between groups, we employed the following 
tests: 1-way analysis of variance (ANOVA, normally distrib-
uted continuous data variables), the Kruskal-Wallis test (non-
normally distributed continuous data variables), and the chi-
squared test (categorical data variables). 
Bivariable analysis was performed initially to identify vari-
ables potentially influencing each outcome, based on statis-
tical rejection criteria of p > 0.1; these variables were then 
included in the multivariable models. 
We used competing-risks regression models (CRR) to test 
adjusted differences in survival across the implant groups, 
where patient death prior to either revision or censoring was 
the competing risk. In contrast to Cox proportional hazards 
(CPH) models, death is treated as a permanent condition that 
prevents future revision from occurring (and so is a compet-
ing event to revision) rather than merely a censoring event. 
CPH analysis tends to overestimate the risk of revision, which 
progressively worsens over time, particularly when the risk of 
death is higher than the risk of revision (for example, in elderly 
patients). Although it could be argued that a young population 
is not particularly susceptible to this inaccuracy at medium-
term follow-up, we felt this approach was the most suitable. 
We used the ‘stcrreg’ command in STATA to implement the 
competing-risks regression based on the proportional sub-haz-
ards model of Fine and Gray (1999). CRR is semi-parametric 
in that the baseline sub-hazard of the event of interest is left 
unspecified, and the effects of covariates are assumed to be 
proportional. Although it is possible to allow the same covari-
ate to have a different effect on the main risk and the compet-
ing risk, we felt that this was unnecessary given that the risk 
of death and revision was unlikely to vary greatly across the 
age range analyzed. Survival times for patients who had not 
undergone revision or had not died were censored at the study 
census date (December 31, 2010). 
We used analysis of covariance (ANCOVA) for testing of 
differences in OHS and EQ5D index change scores. Time 
from implantation to questionnaire completion was included 
in models to evaluate whether differences in duration of fol-
low-up influenced findings. Preoperative scores were included 
within all models, as recommended by the designers of the 
OHS (Murray et al. 2007). 
The reliability of the multivariable statistical models was 
explored in a number of ways: covariates found not to be sta-
tistically significant were excluded from the model, based on 
statistical entry criteria (p < 0.1); the same covariates were 
fitted forward and reverse stepwise manually to ensure that 
findings were not qualitatively affected in the final model, 
with any inconsistency reported. We then re-evaluated the 
final models as a directly entered model (non-stepwise), 
assessed by exploring 2-way interactions between covari-
ates and, for the survival analysis, assessed for the assump-
tion of constant proportionality over time. Clustering of data 
may have an adverse effect on the results of one particular 
group, especially in registry studies where comparison groups 
are relatively small. For example, if a poorly performing hos-
pital or surgeon contributes disproportionally to one group, 
the results of that group may be incorrectly poor. We did not 
table 3. Patient demographics for the national Joint registry-Proms a linked population studied, by implant group
 Cemented Hybrid Cementless Resurfacing 
 Best Others Best Others Best Others Best Others p-value b
Number (%) 111 (6) 52 (3) 118 (6) 213 (11) 159 (8) 1,117 (56) 187 (9) 57 (3) 
Age, median (range) 56 (37–60) 57 (48–60) 54 (30–60) 56 (28–60) 57 (39–60) 54 (25–60) 52 (32–60) 54 (35–60) < 0.001
Females, n (%) 70 (63) 37 (72) 73 (62) 147 (69) 82 (52) 671 (60) 8 (4) 41 (72) < 0.001
ASA c         
 1 34 (31) 11 (21) 44 (37)   75 (35)   40 (25) 377 (34)   84 (45) 24 (42) < 0.001
 2 63 (57) 33 (64) 67 (57) 123 (58) 109 (69) 687 (62) 101 (54) 31 (54) 
 3+ 14 (13)   8 (15)   7 (6)   15 (7)   10 (6)   53 (5)     2 (1)   2 (4) 
BMI, mean (SD) 29 (6) 30 (6) 30 (5)   30 (6)   31 (5)   30 (6)   29 (4) 29 (6)
 (range) d  (19–59) (19–49) (20–47)   (18–50)   (17–46)   (18–65)   (18–45) (19–43) 0.7
a PROMs: patient-reported outcome measures; 
b Statistical notes: 1-way ANOVA was used for normally distributed data, Kruskal-Wallis test for non-normally distributed data, and chi-squared 
  test for proportions;
c ASA: American Society of Anaesthesiologists; 
d BMI: body mass index, kg/m2 (data based on 1,293 procedures (64%)).
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adjust for clustering. However, previous registry analyses have 
found little difference in results when attempting this adjust-
ment (Smith et al. 2012b).
The results of survival analysis are presented as hazard ratios 
(HRs). Statistical models for the change scores were evaluated 
with the margins function in STATA in order to provide pre-
dicted values separately for each of the implant groups. The 
p-values refer to statistical tests of the differences between 
the reference implant (cemented Exeter with a Contemporary 
flanged PE cup and 28- or 32-mm metal or ceramic head) and 
the 7 others. Significance was assumed at p < 0.05. Estimates 
are reported with 95% confidence intervals (CIs). All models 
were fitted using STATA software version 12. For the purpose 
of identification, parameter estimates with probabilities < 5% 
were considered significant, with further consideration of the 
clinical importance of magnitude of estimates.
Costs for specific implant combinations were provided by 
NHS Wales (all 7 units within Wales) and an NHS supply 
chain (buyers on behalf of 30 units within the English NHS). 
The highest and lowest prices paid for implants during 2012 
were analyzed and a modal cost was provided for each of the 
implant components. These costs represent actual prices paid, 
after discounts but excluding value-added tax (VAT) at 20% 
and the NJR levy fee (£20, which is included in the cost of 
each implant). Costs presented also include acetabular screws 
(for cementless cup fixation) when used, the commonest 
cement used for each implant type, femoral cement restrictors, 
and all the equipment required to mix and perform pressurized 
cementation. For the purposes of this analysis, we assumed 
that theater use and length of stay were similar for all types of 
replacement; thus, differences between implant combination 
costs approximate to differences in NHS costs. £1 is equiva-
lent to €1.22 and to $1.70 (correct as of May 7, 2014).
Explicit patient consent was taken for both the NJR and 
PROMs data collection. Further ethics approval is not required 
for registry studies in the UK.
results
Patient-reported outcomes were available for 2014 procedures 
(8.2%), comprising cemented (163, 11% of NJR data), hybrid 
(331, 10%), cementless (1,276, 13%), and resurfacing (244, 
2.3%) replacements (Table 4). Preoperative OHS and EQ5D 
indices were similar across implant groups, except the large-
head resurfacing group (“best”) where patients had a 3.3 to 
6.0 times higher preoperative OHS. Postoperative OHS values 
were generally lower in the cemented group, but postoperative 
EQ5D indices were similar in all groups. There were no statis-
tically significant differences between groups regarding those 
who reported their satisfaction with the procedure and those 
who reported that the operation had been successful (Table 4). 
table 4. Patient-reported outcomes for populations studied, by implant group
 Cemented Hybrid Cementless Resurfacing 
 Best Others Best Others Best Others Best Others p-value a
Number (%) 111 (6) 52 (3) 118 (6) 213 (11) 159 (8) 1,117 (56) 187 (9) 57 (3) 
Oxford hip scores         
 Preoperative
     mean (SD) 19 (9) 16 (7) 19 (8) 18 (8) 17 (7) 18 (8) 22 (8) 19 (8) 0.02
      range   3–40   3–33   4–37   1–36   2–39   2–46   4–43   4–37 0.02
 Postoperative, 
     median (range) 41 (0–48) 40 (4–48) 43 (8–48) 43 (7–48) 42 (4–48) 43 (2–48) 46 (2–48) 43 (5–48) < 0.001
EQ5D index         
 Preoperative, 
    mean (SD)   0.40 (0.30)  0.28 (0.32)  0.41 (0.32)  0.35 (0.33)  0.32 (0.31)  0.35 (0.32)  0.47 (0.31)  0.38 (0.34)  0.3
      range -0.24–0.85 -0.18–0.80 -0.24–0.80 -0.59–0.81 -0.35–0.73 -0.25–1 -0.24–1 -0.24–0.81
 Postoperative, 
    median  0.81  0.73  0.81   0.82  0.80  0.82  1.00  0.81 < 0.001
      range -0.59–1 -0.02–1 -0.24–1 -0.35–1 -0.07–1 -0.24–1 -0.35–1 -0.24–1 < 0.001
Satisfaction (n, %)         
 Good to excellent   99 (89) 44 (85) 110 (93) 198 (93) 150 (94) 1,033 (93) 170 (91) 50 (88) 0.3
 Poor/fair   12 (11)   8 (15)     8 (7)   15 (7)     9 (6)      84 (8)   17 (9)   7 (12) 
Success (n, %)         
 Better 105 (95) 47 (90) 113 (96) 207 (98) 155 (98) 1,072 (96) 181 (97) 53 (93) 0.3
 About the same 
    or worse     6 (5)   5 (10)     5 (4)     6 (3)     4 (3)      45 (4)     6 (3)   4 (7) 
Time from op. to 
 PROMs complete, 
 mean days (SD) 213 (32) 219 (37) 211 (26) 210 (28) 210 (30) 210 (28) 272 (45) 269 (49) < 0.001
    range 188–343 186–329 186–315 183–332 187–350 183– 361 186–360 186–353 
PROMs: patient-reported outcome measures.
a Statistical notes: 1-way ANOVA was used for normally distributed data, Kruskal-Wallis test for non-normally distributed data, and chi-squared 
test for proportions.
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In women, revision was higher in “other” (hard-bearing 
or small-stem) cementless implants (HR = 3.4, CI: 1.1–11) 
and resurfacings (“best”, large head: HR = 5.0, CI: 1.5–17; 
“other”, small head: HR = 6.7, CI: 2–30) when compared to 
the reference (cemented) group. The “best” hybrid group (solid 
shell with a CoC or metal/ceramic on highly crosslinked PE) 
had similar implant survival (HR = 1.4, CI: 0.3–6) (Table 5). 
Greater improvements in OHS were seen in the hybrid groups 
(“best”: 22, CI: 20–24; “other”, multi-hole shells or standard 
PE liner: 22, CI: 20–24) and the cementless groups (“best”, PE 
liners: 21, CI: 19–23; “other”: 22, CI: 22–23) when compared 
£3,551 (Table 11). Cost data were obtained from units across 
England and Wales.
Discussion
This large cohort study using medium-term stratified revision-
risk NJR-PROMs linked data comparing types of hip replace-
ment in patients below 60 years of age showed no advantage 
of resurfacing or cementless implants over standard cemented 
hip replacement in male patients. For women, functional 
table 6. Patient-reported outcome change scores following hip replacement in female patients < 
60 years of age (simple and multivariable analyses)
 Simple Multivariable
 Value 95% CI p-value Value 95% CI p-value
Change in Oxford hip score (n = 1,129)     
 Best cemented (n = 70) 18.0 15.6–20.4  Ref. 18.2 16.1–20.3 Ref.
 Other cemented (n = 37) 22.2 18.8–25.5 0.051 21.7 18.8–24.6 0.052
 Best hybrid (n = 73) 21.2 18.8–23.6 0.06 22.3 20.2–24.3 0.006
 Other hybrid (n = 147) 22.2 20.5–23.9 0.006 21.9 20.4–23.3 0.005
 Best cementless (n = 82) 23.1 20.8–25.3 0.003 21.3 19.4–23.3 0.03
 Other cementless (n = 671) 22.1 21.3–22.9 0.002 22.2 21.6–22.9 < 0.001
 Best resurfacing (n = 8) 29.4 22.2–36.5 0.003 26.6 20.2–33.0 0.01
 Other resurfacing (n = 41) 22.0 18.8–25.2 0.05 21.0 18.1–24.0 0.1
Change in EQ5D index (n = 1,129)      
 Best cemented (n = 70) 0.367 0.280–0.453  Ref. 0.407 0.347–0.466  Ref.
 Other cemented (n = 37) 0.458 0.334–0.581 0.2 0.432 0.348–0.517 0.6
 Best hybrid (n = 73) 0.462 0.375–0.548 0.1 0.486 0.428–0.545 0.06
 Other hybrid (n = 147) 0.462 0.401–0.523 0.1 0.453 0.411–0.495 0.2
 Best cementless (n = 82) 0.453 0.372–0.535 0.2 0.430 0.372–0.487 0.6
 Other cementless (n = 671) 0.440 0.412–0.468 0.1 0.438 0.418–0.457 0.3
 Best resurfacing (n = 8) 0.623 0.377–0.870 0.054 0.517 0.338–0.696 0.2
 Other resurfacing (n = 41) 0.454 0.341–0.567 0.2 0.421 0.338–0.503 0.8
table 5. risk of revision following hip replacement in patients aged < 60 years of age (simple and 
multivariable analyses)
 Simple Multivariable
 HR 95% CI p-value HR 95% CI p-value
Females (n = 11,622)      
 Best cemented (n = 548) 1   1  
 Other cemented (n = 412) 3.06 0.81–11.5 0.1 3.12 0.83–11.8 0.1
 Best hybrid (n = 642) 1.42 0.34–5.94 0.6 1.39 0.33–5.78 0.7
 Other hybrid (n = 1,340) 2.87 0.85–9.65 0.1 2.78 0.83–9.35 0.1
 Best cementless (n = 454) 1.47 0.30–7.24 0.6 1.50 0.30–7.38 0.6
 Other cementless (n = 4,880) 3.45 1.10–10.9 0.03 3.35 1.06–10.6 0.04
 Best resurfacing (n = 432) 5.12 1.50–17.5 0.009 4.95 1.45–16.9 0.01
 Other resurfacing (n = 2,914) 6.57 2.09–20.6 0.001 6.36 2.02–30.0 0.002
Males (n = 13,087)      
 Best cemented (n = 337) 1   1  
 Other cemented (n = 255) 0.78 0.17–3.46 0.7 0.77 0.17–3.45 0.7
 Best hybrid (n = 498) 0.48 0.11–2.16 0.3 0.48 0.11–2.16 0.3
 Other hybrid (n = 758) 1.40 0.45–4.35 0.6 1.34 0.43–4.17 0.6
 Best cementless (n = 466) 0.62 0.14–2.79 0.5 0.62 0.14–2.78 0.5
 Other cementless (n = 3,717) 1.51 0.55–4.18 0.4 1.46 0.53–4.05 0.4
 Best resurfacing (n = 6,247) 1.01 0.37–2.76 1.0 1.02 0.37–2.78 1.0
 Other resurfacing (n = 809) 2.08 0.72–6.00 0.2 2.06 0.71–5.97 0.2
 
with the “best” cemented (18, CI: 
16–20). The “best” resurfacing 
procedures showed good results, 
but this was based on only 8 pro-
cedures (Table 6). EQ5D indices 
were similar in all groups.
In men, improvements in revi-
sion (Table 5) and PROMs were 
equivalent in all groups when 
compared to the reference (Table 
7). 
Tests for interaction (multipli-
cative) between covariates and 
for time-dependency were not 
statistically significant. Forward 
and reverse stepwise model con-
struction led to the same final 
models. Body mass index (BMI) 
was selected as a variable within 
the competing-risks survival 
model for men. However, this 
approach excluded 63% of data. 
BMI was therefore excluded and 
the model was constructed with 
age and ASA group. The output 
from these models (simple and 
multivariable with either BMI or 
age and ASA group included) is 
shown in Table 8 (Supplementary 
data). Variables included in the 
statistical models, and their sig-
nificance levels within the final 
models, are shown in Tables 9 
and 10 (Supplementary data).  
Implant cost data showed the 
standard cemented replacement 
in this analysis to be the cheapest 
(median and modal price: £928, 
with a range from £899 to £1,250). 
Resurfacing implants ranged 
from £1,662.01 to £2,472.34. A 
cementless 36-mm CoC implant 
cost the NHS between £2,064 and 
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outcome was better with hybrid and cementless implants. 
Although revision risk was similar to that of cemented for the 
best cementless and hybrid implants, the risk was 3.5 times 
higher with the commonly used hard-bearing cementless 
implants. Material costs, approximating to NHS costs, were 
lowest with a standard cemented hip replacement and high-
est with hard-bearing cementless implants. These findings are 
important for clinicians and healthcare providers to determine 
the most suitable and cost-effective hip implants for young 
patients with osteoarthritis. 
table 7. Patient-reported outcome scores following hip replacement in male patients < 60 years of 
age (simple and multivariable analyses)
 Simple Multivariable
 Value 95% CI p-value Value 95% CI p-value
Change in Oxford hip score (n = 885)      
 Best cemented (n = 41) 18.4 15.4–21.4  Ref. 20.1 17.6–22.7 Ref.
 Other cemented (n = 15) 17.9 12.9–22.9 0.8 17.9 13.7–22.1 0.4
 Best hybrid (n = 45) 21.0 18.1–23.8 0.2 21.0 18.5–23.4 0.6
 Other hybrid (n = 66) 21.6 19.2–24.0 0.1 20.8 18.8–22.8 0.7
 Best cementless (n = 77) 20.4 18.2–22.6 0.3 19.8 17.9–21.6 0.8
 Other cementless (n = 446) 20.9 19.9–21.7 0.1 20.3 19.6–21.1 0.9
 Best resurfacing (n = 179) 19.7 18.3–21.2 0.5 20.8 19.5–22.1 0.6
 Other resurfacing (n = 16) 18.4 13.6–23.3 1.0 20.0 15.8–24.2 1.0
Change in EQ5D index (n = 885)      
 Best cemented (n = 41) 0.368 0.262–0.475  Ref. 0.392 0.318–0.467  Ref.
 Other cemented (n = 15) 0.397 0.219–0.574 0.8 0.336 0.212–0.459 0.4
 Best hybrid (n = 45) 0.255 0.157–0.354 0.1 0.325 0.255–0.394 0.2
 Other hybrid (n = 66) 0.419 0.340–0.498 0.5 0.413 0.357–0.469 0.7
 Best cementless (n = 77) 0.395 0.320–0.470 0.7 0.388 0.335–0.442 0.9
 Other cementless (n = 446) 0.410 0.379–0.441 0.5 0.396 0.374–0.417 0.9
 Best resurfacing (n = 179) 0.370 0.321–0.419 1.0 0.398 0.361–0.435 0.9
 Other resurfacing (n = 16) 0.307 0.142–0.472 0.5 0.357 0.238–0.476 0.6
table 11. Cost of specific hip implants (nHS costs 2011/12). the figures are based on actual implant costs paid to manufacturers 
by nHS Wales (7 trusts) and nHS supply chain (30 trusts in england), excluding value-added tax (Vat, 20%) and nJr levy costs 
(£20). £1 is equivalent to €1.22 and to $1.70 (correct as of may 7, 2014)
   Costs (£)
  Modal  Low  High 
Best cemented   
 Exeter stem / 28-mm metallic head / flanged Contemporary cup a  928 899 1,250
 Exeter stem / 32-mm ceramic head / flanged Contemporary cup a 1,343 1,183 1,580
Other cemented   
 Exeter stem / 26-mm metallic head / hooded Contemporary cup a 928 899 1,250
Best hybrid   
 Exeter stem / 32-mm metallic head / highly crosslinked polyethylene liner / solid-back Trident shell a 1,465 1,440 2,092
 Exeter stem / 36-mm ceramic head / ceramic liner / solid-back Trident shell a 1,780 1,780 2,619
Other hybrid   
 Exeter stem / 28-mm metallic head / conventional polyethylene liner / multi-hole Trident shell a 1,405 1,405 2,040
Best cementless   
 Corail stem / 28-mm metallic head / conventional polyethylene liner / Pinnacle shell 1,587 1,587 2,722
Other cementless   
 Corail stem / 36-mm metallic head / metallic liner / Pinnacle shell 1,791 1,703 2,924
 Corail stem / 36-mm ceramic head / ceramic liner / Pinnacle shell 2,210 2,064 3,551
Best resurfacing   
 Birmingham Hip Resurfacing using head size ≥ 48 mm a 1,944 1,662 2,472
Other resurfacing   
 Birmingham Hip Resurfacing using head size < 48 mm a 1,944 1,662 2,472
a Including cement (cemented implants, 4 mixes of Heraeus Palacos R+G at £26.75 per mix; hybrid, 2 mixes of Palacos R+G; 
resurfacing, 1 mix of Stryker Antibiotic Simplex at £27.72), mixing set (Optivac £44.29, 2 sets for fully cemented), cement restrictor 
(Hardinge £22.00, not resurfacing). For multi-hole Trident shells, costs of 2 Stryker screws are included (£40 per screw). For Pinnacle 
shells, the cost of 2 screws for half of the implants is included (£54.05 per screw). 
Note: Exeter stems 44/5, 44/6, and all 50 offsets increase cost by £614.27 (< 5% Exeter stems) (Jameson et al. 2012).
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We have not found any previous analyses describing strati-
fied implant revision-risk data, patient-reported outcomes, and 
material costs for specific implants in young patients requir-
ing hip replacement. However, the findings may have some 
limitations. As with all database analyses, the study design was 
observational and therefore vulnerable to omitted variables, 
which may have confounded our findings. Potentially impor-
tant variables such as race, socioeconomic status, patient expe-
riences, and levels of perioperative pain were unavailable, yet 
they are known to influence certain patient outcomes such as 
satisfaction (Hamilton et al. 2013). In addition, important clini-
cal information such as radiological data was not available. 
A decision about a particular patient’s surgical treatment 
is based on patient-related, surgical, and unit factors, and is 
not randomly determined. Patients who receive cementless or 
resurfacing implants may be more aware of implant choice 
and they may be more highly educated. Although statistical 
adjustment can help, a large proportion of variation within 
the models remains unexplained. There is also the possibility 
of over-adjustment, which may influence the precision of the 
results. However, despite the inherent limitations of statistical 
adjustment in cohort studies, the variables we selected in the 
models appear logical. Some surgical factors such as volume, 
grade of surgeon, and approach have been included in analy-
ses, but analysis of the effects of data clustering (in terms of 
surgeon and unit) was not possible. 
As a result of limiting the study to specific brands and 
stratifying implant options, the numbers in some groups 
were low and there may have been bias. The PROMs feasi-
bility pilot indicated that the minimum numbers of PROMs 
required within each comparison group were in the order of 
150 for identification of meaningful differences (Browne et 
al. 2007). The analyses were possibly underpowered to detect 
differences between implants, and this might—in isolation—
explain the lack of significant findings in men. However, 
similar numbers gave clearly significant findings in women. 
Qualitatively, this is unlikely to have occurred by chance given 
the consistent interaction with gender, although this analysis 
could usefully be replicated in other future database analyses 
to correlate theses findings.
The NJR currently only covers medium-term survival; many 
procedures have short follow-up. Polyethylene wear-associ-
ated revision may occur in greater numbers beyond 10 years, 
and hard bearings may ultimately have greater longevity, but 
there is currently no evidence to support this. A systematic 
review of worldwide registry and cohort study data failed to 
show any benefit of other bearings over metal-on-PE (MoP) 
bearings (Sedrakyan et al. 2011). Furthermore, Australian 
joint registry data suggest that metal on highly crosslinked 
PE has the lowest 10-year revision risk (Australian National-
Joint Registry 2012) and dislocation rates are higher with CoC 
bearings (Sexton et al. 2009). In England and Wales, the use 
of MoM has declined dramatically over the last 5 years due to 
concerns about metal wear debris reactions (Medicines and 
Healthcare products Regulatory Agency 2011, England and 
Wales National Joint Registry 2012). 
The validity of NJR data has been questioned, with loss 
of data or under-reporting of revision numbers a possibility, 
although this should affect each group equally. The PROMs 
data are recorded at 6 months only. This may be too early for 
determination of the success of a joint replacement. However, 
the Oxford group has published data showing that PROMs 
improve to 12 months, with the greatest improvement in 
the first 3 months. No improvements were seen between 12 
months and 5 years, suggesting that the results of our short-
term study are a reliable indication of longer-term outcome 
(Andrew et al. 2008, Judge et al. 2013). There may be selec-
tion bias in the PROMs data, as response rates may be differ in 
patients of different ages, different socioeconomic groups, and 
different races. However, we could not assess whether there 
was any bias in completion and return of PROMs, as no details 
were available regarding the number of questionnaires sent 
out or returned. The point at which a patient undergoes a hip 
procedure may also be different (reflecting the need to adjust 
for preoperative scores) depending on age, expectations, and 
occupation. Patients undergoing resurfacing tended to have 
higher preoperative scores. This may in turn limit their ability 
to improve after joint replacement, due to the ceiling effect in 
the OHS and EQ5D index. 
The discrepancy between the ratio of NJR-PROMS linked 
episodes to total NJR episodes across implants (1:10 for 
cemented vs. 1:50 for resurfacing) is difficult to explain, but 
may be due to a generally younger resurfacing population, or 
because there was a higher proportion of resurfacings in the 
private sector (for which PROMs are not available). This may 
limit the conclusions that can be drawn from the resurfacing 
data.
Pennington et al. (2013) recently published a paper on cost 
effectiveness using NJR, PROMs, and implant cost data, 
which compared types of hip replacement. Hybrid implants 
were found to have the most cost-effective profile. As in our 
study, the authors found that cementless implants offered no 
net advantage while being more costly. However, there were a 
number of limitations, which may have influenced the reliabil-
ity of their results: resurfacings were not included; all brands 
within each group were analyzed together, with no adjustment 
for the heterogeneity of implants; and analyses were limited to 
MoP bearings only.
Although hybrid implants appeared to offer a balance 
between implant survival and functional benefit for young 
women in the present study, it must be stressed that this 
requires adequate fixation with a solid acetabular shell. Analy-
sis of the hybrid data previously demonstrated that multi-hole 
shell (with screw fixation) had poorer survival ( Jameson et 
al. 2013b). The risk of revision in women with this combina-
tion was 3 times greater than for the best cemented implant 
in our data, which approached significance (p = 0.1). While 
a cemented procedure will have reproducible results, the suc-
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cess of a cementless cup is reliant on adequacy of the press-
fit. In addition, there is no obvious explanation for the dif-
ference in the effect of implant type on men and women in 
our study. It is reasonable to suggest, therefore, that a surgeon 
using cemented implants in the majority of patients could also 
use the same implants in young women with acceptable and 
reproducible results. 
Despite the poor results of cemented implants during the 
1980s, more contemporary analyses have shown equivalent or 
better survival compared to cementless implants (Busch et al. 
2010, Pakvis et al. 2011, Schmitz et al. 2013, Toossi et al. 
2013), supporting the encouraging results of registry data. The 
findings from the earlier studies may have been influenced by 
previous generations of implants and poor cementation tech-
niques. Data from our previous study suggest that the Exeter 
Contemporary system using the flanged cup design and a head 
size of 28 mm or greater had good and reproducible results 
in all patients, from all surgeons across England and Wales 
(Jameson et al. 2012a). Moreover, no additional survival ben-
efit was seen when 32-mm and/or ceramic heads were used in 
place of 28-mm metal heads. In addition, head size and bear-
ing type appear to have no influence on PROMs and complica-
tions across a range of implant options ( Jameson et al. 2014). 
Although our study found no benefit of a resurfacing pro-
cedure in young men over a standard cemented replacement 
(despite inclusion of only the best-performing brand and use 
of large femoral head sizes), there may be long-term implant 
survival benefit. However, it is known that high-volume 
surgeons have lower revision rates in complex procedures 
(Jameson et al. 2012b, Baker et al. 2013), and there remain 
concerns regarding the local and systemic complications asso-
ciated with MoM bearings (Haddad et al. 2011); the regula-
tory body in the United Kingdom currently stipulates that all 
MoM implants should be reviewed on an annual basis (Medi-
cines and Healthcare products Regulatory Agency 2011). In 
addition, Costa et al. (2012) found no evidence of benefit at 
12 months when patients were randomized to resurfacing 
or hip replacement. A cost analysis performed on the same 
cohort found that resurfacing offered only very short-term 
efficiency benefits over THA in a selected patient group (Edlin 
et al. 2012). A dramatic fall in the use of resurfacings, with 
clustered use predominantly in the young male group during 
2011, would suggest that surgeons in England and Wales are 
responding to the evidence (England and Wales National Joint 
Registry 2012). 
Cementless implants with mid/large stems and MoP or CoP 
performed well in young women with equivalent survival and 
better improvement in OHS compared to cemented implants. 
However, this group represented only 8.5% of cementless 
implants used in women (454 of 5,334). Moreover, 39% of 
females required a small stem size (7,932 of 20,166) in a 
previous analysis ( Jameson et al. 2013a) and implant fail-
ure increased with higher BMI, suggesting that the group of 
women that could benefit is small. Proponents of fully cement-
less procedures argue that operative time is also shorter, 
increasing patient turnover and theater use. However, there is 
no good evidence of this. Such an efficiency benefit is relevant 
only when implants offer equivalent clinical benefit and mate-
rial costs, a finding that is not supported by our analysis. The 
use of cement on the femoral side has many advantages that 
outweigh the disadvantage of a slightly longer operating time 
(Murray 2011).
We found no advantage in the use of fully cementless or 
resurfacing implants in young patients when compared with 
a standard cemented hip replacement. For young women, 
hybrid implants that employ adequate press-fit acetabular fixa-
tion and either highly crosslinked PE or ceramic bearings may 
provide the best balance of early improvement in outcome, 
revision risk, and cost.
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